Anti-idiotype vaccine (Bayer)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-idiotype vaccine (Bayer)

Drug Alias Nametobacco plant-derived anti-idiotype vaccine (subcutaneous magnICON, NHL)tobacco plant-derived anti-idiotype vaccine (subcutaneous magnICON, non-Hodgkin's lymphoma)

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsLymphoma, Non-Hodgkin

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBayer AG

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBayer AG

Active IndicationsN/A

Inactive IndicationsLymphoma, Non-Hodgkin

Other Information

ATC CodeN/A